ST.27-legal status data

The legal status information displayed below is based on WIPO Standard ST.27 and of a purely informative nature. Binding information on the status of the IP right is only available in DPMAregister (Show details).

DE file number: 60 2013 056 987.8, EP file number: 16 19 1716.6 (Designation/title: N-((4,6-DIMETHYL-2-OXO-L,2-DIHYDROPYRIDIN-3-YL)METHYL)-5-(ETHYL (TETRAHYDRO-2H-PYRAN-4-YL)AMINO)-4-METHYL-4'-(MORPHOLINOMETHYL)-[L,1'-BIPHENYL]-3-CARBOXAMIDE HYDROBROMIDE ZUR VERWENDUNG IN DER BEHANDLUNG EINER ZELLPROLIFERATIVEN KRANKHEIT DES HÄMATOLOGISCHEN SYSTEMS)

↩ Details

Tabular representation
Current state: Active, Current state: Grant

Key event history
No. Key Event Code Key Event Name Event Date Effective Date Effective Date sorted ascending Publication Date To Stage
1 Q10 Document published Jun 28, 2017Jun 28, 2017 Filing
2 Q10 Document published Aug 10, 2017Aug 10, 2017Aug 10, 2017 Filing
3 Q10 Document published Jun 19, 2019Jun 19, 2019 Examination
4 Q10 Document published Jul 18, 2019Jul 18, 2019Jul 18, 2019 Examination
5 F10 IP right granted Jun 3, 2020Jun 3, 2020Aug 27, 2020 Grant
Detailed event history
No. Detailed Event Code Detailed Event Name Event Date Effective Date Effective Date sorted ascending Publication Date To Stage
1 Q12 Application published Jun 28, 2017Jun 28, 2017 Filing
2 Q10 Document published Aug 10, 2017Aug 10, 2017Aug 10, 2017 Filing
3 Q10 Document published Jun 19, 2019Jun 19, 2019 Examination
4 Q10 Document published Jul 18, 2019Jul 18, 2019Jul 18, 2019 Examination
5 F10 IP right granted Jun 3, 2020Jun 3, 2020Aug 27, 2020 Grant

Graphical representation

Below you will see a simplified graphical representation of the legal status information, which is based on WIPO Standard ST.27 using the "Overall Patent/SPC Prosecution Model" defined therein.

Graphical representation of the ST.27 legal status data